Elevated cortactin activation by phosphorylation has been revealed to promote cancer progression in breast cancer and malignant melanoma by, e.g. enhancing the interaction of tumor cells with endothelial cells and elevating the tumor cell’s capacity for cell invasion into tissues [36, 37]. This evidence concerns the gene CTTN and breast carcinoma.